Tag: NeoCast
EMBO-02 study indicates rapid cSDH resorption and pain-free treatments with NeoCast...
Arsenal Medical has announced late-breaking data from the EMBO-02 clinical study evaluating NeoCast—a next-generation, shear-responsive liquid embolic agent—in the treatment of patients with chronic...
Arsenal Medical launches EMBO-02 study to assess NeoCast in cSDH treatment
Arsenal Medical today announced the initiation of the EMBO-02 clinical study of NeoCast in the treatment of chronic subdural haematomas (cSDHs). NeoCast is a...
Novel liquid embolic agent meets primary feasibility and safety endpoints in...
Arsenal Medical has announced that NeoCast—a first-of-its-kind, shear-responsive liquid embolic material designed for deep distal penetration—met its primary feasibility and safety endpoints in the...
